HealthInvest Partners AB Buys Harmony Biosciences Holdings Inc, Rigel Pharmaceuticals Inc, Lannett Co Inc, Sells Ironwood Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Cigna Corp

• New Purchases: HRMY, RIGL, LCI, UTMD, ZGNX, ALDX, EOLS, ABC, URGN, LJPC,
• Reduced Positions: IRWD, MCK, BMY, ABBV, CAH, SUPN, ARAY,
• Sold Out: VRTX, CI,

For the details of HealthInvest Partners AB's stock buys and sells, go to https://www.gurufocus.com/guru/healthinvest+partners+ab/current-portfolio/portfolio

1. Ironwood Pharmaceuticals Inc (IRWD) - 685,000 shares, 13.40% of the total portfolio. Shares reduced by 54.93%
2. Supernus Pharmaceuticals Inc (SUPN) - 335,000 shares, 13.38% of the total portfolio. Shares reduced by 36.79%
3. Accuray Inc (ARAY) - 1,860,000 shares, 11.00% of the total portfolio. Shares reduced by 19.13%
4. Harmony Biosciences Holdings Inc (HRMY) - 185,000 shares, 10.62% of the total portfolio. New Position
5. Rigel Pharmaceuticals Inc (RIGL) - 1,765,000 shares, 9.60% of the total portfolio. New Position

HealthInvest Partners AB initiated holding in Harmony Biosciences Holdings Inc. The purchase prices were between $25.68 and $38.61, with an estimated average price of $32.22. The stock is now traded at around $42.920000. The impact to a portfolio due to this purchase was 10.62%. The holding were 185,000 shares as of 2021-09-30.

HealthInvest Partners AB initiated holding in Rigel Pharmaceuticals Inc. The purchase prices were between $3.5 and $4.5, with an estimated average price of $3.95. The stock is now traded at around $3.235000. The impact to a portfolio due to this purchase was 9.6%. The holding were 1,765,000 shares as of 2021-09-30.

HealthInvest Partners AB initiated holding in Lannett Co Inc. The purchase prices were between $2.91 and $4.83, with an estimated average price of $4.04. The stock is now traded at around $2.209000. The impact to a portfolio due to this purchase was 7.98%. The holding were 1,775,000 shares as of 2021-09-30.

HealthInvest Partners AB initiated holding in Utah Medical Products Inc. The purchase prices were between $84.89 and $97.16, with an estimated average price of $88.29. The stock is now traded at around $104.040000. The impact to a portfolio due to this purchase was 5.84%. The holding were 42,000 shares as of 2021-09-30.

HealthInvest Partners AB initiated holding in Zogenix Inc. The purchase prices were between $13.11 and $18.46, with an estimated average price of $15.64. The stock is now traded at around $16.011500. The impact to a portfolio due to this purchase was 5.01%. The holding were 220,000 shares as of 2021-09-30.

HealthInvest Partners AB initiated holding in Aldeyra Therapeutics Inc. The purchase prices were between $7.94 and $11.31, with an estimated average price of $9.2. The stock is now traded at around $9.143400. The impact to a portfolio due to this purchase was 4.08%. The holding were 310,000 shares as of 2021-09-30.

HealthInvest Partners AB sold out a holding in Vertex Pharmaceuticals Inc. The sale prices were between $181.39 and $202.99, with an estimated average price of $195.37.

HealthInvest Partners AB sold out a holding in Cigna Corp. The sale prices were between $200.16 and $238.3, with an estimated average price of $217.75.